Activity of JNJ-Q2, a Novel Fluoroquinolone, Tested against Neisseria gonorrhoeae, Including Ciprofloxacin-Resistant Strains
Activity of JNJ-Q2, a Novel Fluoroquinolone, Tested against Neisseria gonorrhoeae, Including Ciprofloxacin-Resistant Strains, Lead author: Farrell DJ, presented at 49th annual Infectious Diseases Society of America (IDSA), October 20 – 23, 2011, Boston, MA